Page last updated: 2024-12-07

rx-ra 69

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RX-RA 69: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132466
SCHEMBL ID10659585
MeSH IDM0108829

Synonyms (11)

Synonym
rx-ra 69
8-benzylthio-4-morpholino-2-piperazino-pyrimido(5,4-d)pyrimidine
pyrimido(5,4-d)pyrimidine, 4-(4-morpholinyl)-8-((phenylmethyl)thio)-2-(1-piperazinyl)-
8-benzylthio-4-morpholino-2-piperazinylpyrimido(5,4-d)pyrimidine
4-(4-morpholinyl)-8-((phenylmethyl)thio)-2-(1-piperazinyl)pyrimido(5,4-d)pyrimidine
77749-49-6
4-(8-benzylsulfanyl-2-piperazin-1-ylpyrimido[5,4-d]pyrimidin-4-yl)morpholine
8-benzylthio-4-morpholino-2-piperazino-pyrimido-[5,4-d]-pyrimidine
LUGKHBNNJJSVLE-UHFFFAOYSA-N
DTXSID40228367
SCHEMBL10659585

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The same dosage is able to prevent the drop in platelet count induced by injecting a large number of tumor cells into mice."( Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse.
Haarmann, W; Lichtner, R, 1982
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]